Pharmacological approaches to methamphetamine dependence: a focused review
- 10 May 2010
- journal article
- review article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 69 (6), 578-592
- https://doi.org/10.1111/j.1365-2125.2010.03639.x
Abstract
Methamphetamine dependence is a serious worldwide public health problem with major medical, psychiatric, socioeconomic and legal consequences. Various neuronal mechanisms implicated in methamphetamine dependence have suggested several pharmacological approaches. A literature search from a range of electronic databases (PubMed, EMBASE, PsycInfo, the NIDA research monograph index and the reference list of clinicaltrials.gov) was conducted for the period from January 1985 to October 2009. There were no restrictions on the identification or inclusion of studies in terms of publication status, language and design type. A variety of medications have failed to show efficacy in clinical trials, including a dopamine partial agonist (aripiprazole), GABAergic agents (gabapentin) and serotonergic agents (SSRI, ondansetron, mirtazapine). Three double-blind placebo-controlled trials using modafinil, bupropion and naltrexone have shown positive results in reducing amphetamine or methamphetamine use. Two studies employing agonist replacement medications, one with d-amphetamine and the other with methylphenidate, have also shown promise. Despite the lack of success in most studies to date, increasing efforts are being made to develop medications for the treatment of methamphetamine dependence and several promising agents are targets of further research.Keywords
This publication has 125 references indexed in Scilit:
- The cardiovascular and subjective effects of methamphetamine combined with γ-vinyl-γ-aminobutyric acid (GVG) in non-treatment seeking methamphetamine-dependent volunteersPharmacology Biochemistry and Behavior, 2009
- Modafinil for the treatment of cocaine dependenceDrug and Alcohol Dependence, 2009
- Effects of Modafinil on Dopamine and Dopamine Transporters in the Male Human BrainJAMA, 2009
- Methamphetamine dependence and human immunodeficiency virus risk behaviorJournal of Substance Abuse Treatment, 2008
- Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependenceDrug and Alcohol Dependence, 2008
- Lobeline effects on tonic and methamphetamine-induced dopamine releaseBiochemical Pharmacology, 2008
- Evaluation of the cardiovascular and subjective effects of rivastigmine in combination with methamphetamine in methamphetamine-dependent human volunteersInternational Journal of Neuropsychopharmacology, 2008
- Lobelane decreases methamphetamine self-administration in ratsEuropean Journal of Pharmacology, 2007
- Kinetic and cardiovascular effects of acute topiramate dosing among non-treatment-seeking, methamphetamine-dependent individualsProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2007
- Effects of topiramate on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition in recently abstinent methamphetamine-dependent individualsProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2007